Posted by Michael Wonder on 10 Sep 2025
Health Canada approves Bylvay (odevixibat) for the treatment of cholestatic pruritus in patients with Alagille syndrome
9 Settember 2025 - Bylvay is the first and only medication approved in Canada for the treatment of both Alagille syndrome and progressive familial intrahepatic cholestasis
Medison and Ipsen announced today that Health Canada has approved Bylvay (odevixibat) for the treatment of cholestatic pruritus in patients 12 months and older with Alagille syndrome.
